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ABS TRACT
Background and objectives: The severity of HIV-1 infection, measured by set-point viral load (SPVL), is
highly variable between individuals. Its heritability between infections quantifies the control the patho-
gen genotype has over disease severity. Heritability estimates vary widely between studies, but differ-
ences in methods make comparison difficult. Phylogenetic comparative analysis offers measures of
phylogenetic signal, but it is unclear how to interpret them in terms of the fraction of variance in SPVL
controlled by the virus genotype.
Methodology: We present computational methods which link statistics summarizing phylogenetic sig-
nal to heritability, h2 in order to test for and quantify it. We re-analyse data from Switzerland and
Uganda, and apply it to new data from the Netherlands. We systematically compare established and
new (e.g. phylogenetic pairs, PP) phylogenetic signal statistics.
Results: Heritability estimates varied by method and dataset. Several methods were consistently able to
detect simulated heritability above h2  0:4, but none below. Pagel’s  was the most robust and
sensitive. The PP method found no heritability in the Netherlands data, whereas Pagel’s  found sig-
nificant heritability only in a narrow subdivision (P = 0.038). Heritability was estimated at h2 = 0.52 (95%
confidence interval 0.00–0.63).
Conclusions and implications: This standardized measure, h2, allows comparability of heritability
between cohorts. We confirm high heritability in Swiss data, but neither in Ugandan data nor in the
Netherlands, where it is barely significant or undetectable. Existing phylogenetic methods are ill-suited
for detecting heritability below h2  0:4, which may nonetheless be biologically important.
KEYWORDS : HIV-1; heritability; phylogenetic comparative analysis; set-point viral load;
phylogenetic signal; virulence
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BACKGROUND AND OBJECTIVES
HIV has a high mutation rate [1, 2] and daily turnover
[3, 4] and therefore adapts rapidly under local select-
ive pressure from the immune system [5, 6, 7] or
antiretroviral drugs [8, 9]. Increasingly there is inter-
est in the transmission of escape [10, 11] or drug
resistance mutations [12], which may enable viral
adaptation to the host population. The rate at which
a trait evolves in response to natural selection is
determined by its heritability.
Recent work has suggested that virulence may
also evolve at the population level [13] by natural
selection towards a level optimal for transmission
[14, 15]. Variation in virulence has a large impact on
mortality and morbidity, so its evolutionary potential
may present challenges or provide opportunities in
public health interventions [16]. For example, vac-
cines which reduce growth rate or toxicity are pre-
dicted to reduce the costs of virulence, to the
vaccinated host and the pathogen. This potentially
raises the optimal virulence, resulting in poorer out-
comes for the unvaccinated individuals [17].
Virulence in HIV is well approximated by set-point
viral load (SPVL), which refers to the density of vir-
ions in the blood during asymptomatic infection.
SPVL is an early prognostic indicator for AIDS, as it
varies by orders of magnitude between individuals,
with high values having faster CD4 cell decline, pro-
gressing more rapidly to AIDS and death [18, 19, 20].
However, it is relatively stable within the individual
[21] meaning that it can be measured at a wide range
of time points in an individuals’ infection [22].
Many host factors influence SPVL (Human
Leukocyte Antigen (HLA) type (reviewed in [23])),
sex [24], ethnicity [25], age [26], co-infections [27,
28]). Specific human genetic markers have been
identified to which 13% of SPVL variation can be
attributed, with a further 9% explained by age, sex
and population structure [29]. Recently, several
studies have indicated that viral factors play a sub-
stantial role in SPVL variation by measuring its her-
itability between infections (reviewed in [30]). Most
of these quantify the similarity in SPVL within trans-
mission pairs, which are sexual couples in which one
has infected the other [31–34].
The phenotype of any organism is controlled
partly by its genome, and partly by its environment.
Throughout this work we define heritability, h2, in the
broad sense as the proportion of total phenotypic
variance (2P) ascribed to genetic variance (
2
G)
[equation (1), [35]]. In the environmental component
of variance, 2E, we conceptually include all host gen-
etic and non-genetic effects, as well as interactions
between host and virus genotype.
h2 ¼ 
2
G
2P
: ð1Þ
Alizon et al. [36] used a phylogenetic comparative
approach to identify phylogenetic signal as a meas-
ure of heritability, without requiring behavioural
data. Phylogenetic signal is the extent to which indi-
viduals with similar traits can be observed to cluster
together on the phylogeny. This approach has the
advantage that any sample of well-characterized pa-
tients could be analysed in this way. However, the
authors did not account for cofactors such as age
and co-infections, which influence the SPVL and may
cluster together on the phylogeny. It is also uncertain
exactly how the quantity measured by the two
methods used (Pagel’s  and Blomberg’s K) should
be interpreted in the context of heritability. We
herein propose a new approach which also uses only
the phylogenetic relationships to determine genetic
proximity of viruses, but additionally links the results
to true heritability, and in some cases allows inclu-
sion of the effect of cofactors on SPVL.
The aims of this study were to evaluate the phylo-
genetic approach for estimating heritability, to com-
pare the efficacy of the various statistics available for
quantifying heritability on simulated and real data, to
use these methods to confirm the presence of herit-
ability in previously analysed data, and to measure
heritability in a dataset from the Netherlands which
has not been previously analysed for this purpose.
METHODOLOGY
Data
Data from Rakai, Uganda
The study population was enrolled in the Rakai
Community Cohort Study in the rural Rakai District
of south-western Uganda. The study methods for
this cohort have been outlined elsewhere [34, 37,
38]. We used those individuals who were sampled
at a single time point in April 1995 (n = 332).
Characteristics of the cohort are shown in
Supplementary Table S1. Serum samples were used
to measure SPVL, with most individuals providing a
single measurement.
The phylogenetic analysis was conducted in
RAxML [39] using the General Time Reversible
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substitution model [40], the  model of rate hetero-
geneity with four distinct rate categories and a pro-
portion of invariant sites [41] (GTR++I), which had
the best score when the alignment was analysed with
ModelTest [42]. The alignment was also analysed
using the Recombination Analysis Tool (RAT [43]),
which found no apparent recombination within the
studied genes (data not shown).
A Simian Immunodeficiency Virus (SIV) outgroup
was included (accession number: AB177846.1). The
phylogeny was constructed from either the gp41
(env) or p24 (gag) sequences (Supplementary Figs
S1 and S2), which were analysed separately because
they have different substitution rates [44]. We also
performed the phylogenetic and heritability analysis
on the subtype A and D sequences separately, due to
apparent imbalance in the joint trees.
Data from Switzerland
The Swiss data were taken from the Swiss HIV
Cohort Study and its integrated genotypic drug re-
sistance database which has been described else-
where [45, 46], and the specific selection has been
analysed in previous work [36, 47, 48]. The phyl-
ogeny, constructed from the reverse transcriptase
and protease components of the pol gene
(Supplementary Fig. S3), had been inferred in this
previous work [36] using PhyML [49] from subtype B
infected individuals for whom at least three viral load
measurements were available after primary infection
and before anti-retroviral therapy (n = 661).
Characteristics of the cohort are shown in
Supplementary Table S2.
Note that PhyML was used for the Swiss data,
compared with RAxML in the other two datasets.
However, we expect the methods to produce very
similar results as both use a hill-climbing algorithm,
likelihood scores are well matched when using the
same nucleotide substitution model, and there is no
evidence for systematic differences in the results [50].
We analysed four subdivisions of the data as in
previous work [36]. The entire dataset (‘All’) fit the
Liberal definition for viral load variability, meaning
that at least three consecutive viral load measure-
ments within the asymptomatic window (6–36
months after first positive viral RNA) remained
within a one-log band of one another. The ‘Strict’
subdivision included only those individuals for
whom the measurements in the asymptomatic win-
dow all sat within the one-log band. Excluding all but
men who have sex with men (MSM) led to the further
subdivisions, ‘MSM’ and ‘MSM Strict’.
Data from Netherlands
The study cohort was provided by the ATHENA na-
tional observational cohort (seroconverters from
1996 or onwards) and the Amsterdam Cohort
Studies (seroconverters before 1996) [51]. We
included only individuals infected with subtype B
between 1985 and 2008, for whom appropriate gen-
etic data and SPVL were available [52] (n = 416).
We define SPVL as the mean of all log10 viral load
measurements taken 6–24 months after the mid-
point between the last negative and the first positive
diagnosis. The phylogeny was reconstructed using a
sequence of length 2064 containing the same elem-
ents of the pol gene as for the Swiss data.
We excluded codons strongly associated with
drug resistance mutations (for details, see
Supplementary Fig. S4). Four subtype C individuals
from the same cohort were used as the outgroup.
The phylogenetic analysis was performed using
ModelTest [42], RAxML [39] and RAT [43] in the same
way as the Rakai cohort, which also identified the
same nucleotide substitution model as appropriate,
and no recombination was detected (data not
shown).
As with the Swiss data, individuals were
categorized as ‘All’, ‘Strict’, ‘MSM’ and ‘MSM
Strict’. Additionally, two further categories, ‘MSM
NL’ and ‘MSM Strict NL’, were created from the
‘MSM’ groups, which excluded individuals not
originating in the Netherlands in order to further
reduce confounding factors.
Trees for simulations were read and manipulated
using the ape package [53] in R [54], which was also
used to plot the trees.
Methods for calculating heritability statistics
A phylogeny, reconstructed from genetic data, is an
approximation of the transmission network.
Phylogenetic signal is a measure of how well trait
values at the tree tips match their relative positions
on the phylogeny, and several established methods
are available to quantify this signal in terms of a
single statistic: the Mantel test [55]; Blomberg’s in-
dependent contrasts, which give us the Blomberg’s
K and PICv (variance of phylogenetic independent
contrasts) statistics [56]; Pagel’s  transformation
[57]; and the Abouheif–Moran (AM) tests [58], of
which there are five variants (‘oriAbouheif’,
‘sumDD’, ‘nNodes’, ‘patristic’, ‘Abouheif’, with the
latter used by default). We also developed two new
methods which allow control of cofactors, the
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phylogenetic pairs (PP) method and the hierarchical
clustering (HC) method, which are described briefly
here.
The PP method identifies pairs of individuals on
the tree which are each other’s closest neighbour,
and these are assumed to be transmission pairs.
Analysis of variance (ANOVA) identifies the degree
to which the transmission partner explains an indi-
vidual’s SPVL. Crucially, the ANOVA approach
allows for the inclusion of cofactors. These are age,
sex and genital ulcer disease in the Rakai dataset
(Supplementary Table S1); age, sex and risk group
in the Swiss dataset (Supplementary Table S2); and
age, sex, risk group, region of origin and the type of
assay used to measure viral load in the Netherlands
dataset (Supplementary Table S3). This method also
ignores individuals who are not part of a phylogen-
etic pair.
The HC method is similar but considers larger
clusters of individuals identified on the phylogeny
by a threshold branch length, and examines the
amount of variance in SPVL explained by the cluster.
Because there is no intuitive ideal cluster size, pro-
portion included or number of clusters to use, the
method integrates over the range of clustering
distances.
All established and new methods are described in
detail in the Supplementary data.
Randomization test
The significance of a test statistic can be measured
as in [56] by comparing the statistic derived from the
data with its distribution under no heritability, which
is the null hypothesis. Randomizing the tips of the
tree by randomly reallocating the tips scrambles any
heritability signal. This is performed 1000 times, and
the analysis is repeated for each. The proportion of
randomized datasets that give a statistic higher than
the true value is the one-tailed P-value for presence
of heritability. When the randomization test was per-
formed for the PP and HC statistics the cofactors
remained with their corresponding SPVL data.
Method of simulating SPVL data on a known
phylogeny
This method uses a simple algorithm to simulate
evolution of a continuous trait on a known phylogeny
for a given heritability. This method is similar to that
used in previous work [36] and is a variation on the
Ornstein–Uhlenbeck process [59, 60], which allows
Brownian motion to occur while constraining the
distribution of the population.
During the simulation, each node on the tree is
assigned a trait value in log10 SPVL, beginning from
the root, which is assigned the mean of the true SPVL
data. Each daughter node is given a SPVL value de-
pending on that of its parent, and on the SPVL dis-
tribution in the whole population. The higher the
heritability, the more the value depends on the
parent.
The SPVL at each subsequent daughter node,
VD [equation (2)], is derived from the parent
node, VP, the value h
2, and the random variable
M which is normally distributed according to the
mean and variance of the population log10 SPVL
(distribution 3).
VD ¼ h2VP+M
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
1 ðh2Þ2
q
, ð2Þ
M  Nð ,2PÞ: ð3Þ
The value h2 is therefore the regression slope be-
tween the trait values at a parent node, VP, and a
daughter node,VD (or an index and secondary case).
This has been demonstrated to be equal to the broad
sense heritability, h2 as defined in equation (1) [61],
and its further implications are discussed in the
Supplementary data. The result is a set of data at
the tips of the tree, simulated with known heritability
h2, which is used for analysis. We have also explored
an alternative method of simulation which allows for
multiple transmission between nodes on the tree,
which is also described in the Supplementary data.
Multiple hypothesis testing to estimating true
heritability and confidence intervals
For each value of h2 between 0 and 1, in increments
of 0.01, 100 simulations are performed and the rele-
vant phylogenetic comparative statistics is
calculated. A hypothesis test for the particular h2 is
then performed with these 100 values. They are
compared with the statistic calculated from the true
data, and the proportion which is lower than the
true statistic becomes the probability P that
the data are consistent with that value of h2. The
values of h2 which produce P-values closest to
0.025, 0.975 and 0.500 become the lower and upper
95% confidence bounds, and the median estimate of
h2, respectively.
A visual distribution of h2 is estimated using
approximate Bayesian computation (ABC), of which
details are given in the Supplementary data.
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Estimate power to detect an effect
To examine the ability of each statistic to detect non-
null heritability, we simulated 100 datasets for each
value of a range (0–1) of h2 values in increments of
0.05. To visualize the relationship between h2 and the
statistic of interest, we calculated the mean and
standard deviation of the phylogenetic comparative
statistics calculated from these 100 simulations. In
order to estimate the power of each statistic to detect
a significant effect at each value of h2, we performed a
randomization test on each simulated dataset, as
described above (see ‘Randomization test’), but with
100 randomizations. For each simulated dataset, the
proportion of randomization tests which find signifi-
cant (P < 0:05) heritability represents the power to
detect an effect at that value of h2.
All methods are available in R code on request
from the corresponding author.
RESULTS
Testing significance in previously analysed data
The significance of heritability from the
randomization test for the Rakai and Swiss data is
shown in Tables 1 and 2, respectively.
A consistent signal was not found in the Rakai
data (Table 1), but in the Swiss data it was more
so (Table 2), and was higher for the smaller subdiv-
isions. We tested the possibility that high signifi-
cance in the smallest group was an artefact of
small tree size, but this was not the case
(Supplementary Table S5). We also tested the ro-
bustness of the results to phylogenetic uncertainty
and found that small levels of perturbation (3%)
have little effect on the results, but as the level of
perturbation increases, the signal weakens accord-
ingly (Supplementary Table S6).
Estimates of heritability in previously analysed
data
Tables 1 and 2 show the medians and confidence
intervals of h2 as estimated by multiple hypothesis
testing (MHT). In the Swiss data, the confidence
intervals exclude zero in several cases. In all of these
instances, the randomization test was also signifi-
cant. However, a significant randomization test did
not always correspond to confidence intervals which
excluded zero, because these are one- and two-tailed
tests, respectively.
The distribution of true heritability was calculated
by ABC using both PP (red) and Pagel’s  (blue) for
each subdivision in the Swiss and Rakai datasets
(Figs 1 and 2). In the Swiss figure, the MSM Strict
subdivision exhibits the distribution of h2 most
removed from zero, which supports the results from
the randomization test and lower confidence
bounds (Table 2). The method using Pagel’s 
exhibits higher heritability in the larger subdivisions.
Similarly in the Rakai cohort, the most significant
result from the randomization test (Table 1) is the
p24 subdivision analysed under Pagel’s , and this is
reflected in the results from ABC, in which the dis-
tribution of estimated h2 is highly positive.
Interestingly, the PP method finds that the most sig-
nificant distribution visually is instead from the gp41
subdivision which is also confirmed by the
randomization test.
We also tested an alternative method of simula-
tion which accounted for differences in branch
length and allowed multiple generations between
two adjacent nodes. We applied this to the Rakai
p24 subtype A data (Supplementary Table S7), and
the alternative gave higher estimates of h2 but wider
confidence intervals.
Heritability was also measured in the Rakai and
Swiss data using a phylogenetic mixed model, which
assumes that the trait is determined by independent
viral and host effects [62]. These results are given in
Supplementary Table S4.
Testing the sensitivity of each statistic
The sensitivity of each phylogenetic comparative
statistic to simulated heritability was explored by
visualizing the relationship between them, and
measuring the power of the statistic to successfully
detect an effect of that size, in the entire Swiss
dataset and the MSM Strict subdivision (Figs 3 and
4, respectively). None of the statistics had substan-
tial power to detect heritability below h2 = 0.4 on any
subdivision, but most had the power to detect an
effect above that level. The Mantel test performed
poorly throughout. Blomberg’s K performed well in
the MSM Strict subdivision, but was insensitive
when applied to the entire Swiss dataset, with only
values above h2 = 0.6 being consistently detected. In
the entire Swiss dataset, the AM statistic appeared
the most sensitive, but in the MSM Strict subdiv-
ision its performance matched that of Pagel’s .
We also tested the power of variants of the HC and
AM tests compared with their default methods
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(‘ward’ and ‘Abouheif’, respectively)
(Supplementary Figs S5 and S6). The default
methods performed equally well or better than any
of the variations.
Application to data from the Netherlands
Supplementary Figure S4 shows the shape of the
phylogeny inferred from the Netherlands data.
These data have not been previously analysed for
heritability, and so to reduce the problem of multiple
testing only two methods, Pagel’s  and PP, were
used to detect and measure heritability in each sub-
division of the data.
Significant heritability was found only in one
subdivision (MSM from the Netherlands
with Strict viral loads) and using one statistic
(Pagel’s ), which gave a heritability estimate of
h2 = 0.52 (Table 3). No effect was found when the
PP method was used. None of the confidence inter-
vals on h2 excluded 0. The estimated distributions of
h2 are shown in Fig. 5.
DISCUSSION
In this study, we developed new methods for detect-
ing and measuring heritability of SPVL using phylo-
genetic relationships and compared them with
established methods on real and simulated data.
Which cohorts exhibit heritability?
Heritability was detected consistently in the MSM
Strict subdivision of the Swiss cohort (Table 2), sup-
porting the previous study of these data which found
significant and high heritability in that subdivision
[36]. Note that in that study, the level of significance
was detected by randomizing the PICv rather than
the K statistic, hence the strong result for PICv in the
MSM Strict subdivision. We also found that several
statistics uncovered significant heritability in all of
the subdivisions of the Swiss data. In many such
cases, the confidence intervals of h2 also excluded
zero, and the estimates for h2 were high (0.44–0.68).
Table 2. The statistics (Z), P-values from a randomization test, medians and confidence intervals of h2
from MHT on the Swiss data
Type of test All (n = 661) Strict (n = 230) MSM (n = 404) MSM Strict (n = 134)
Z P h2 95% CI Z P h2 95% CI Z P h2 95% CI Z P h2 95% CI
PP 0.089 0.817 0.08 (0.00,
0.48)
0.376 0.020 0.61 (0.01,
0.77)
0.009 0.492 0.18 (0.00,
0.53)
0.595 0.005 0.68 (0.12,
0.82)
HC complete 0.008 0.214 n.d. n.d. 0.045 0.038 n.d. n.d. 0.020 0.096 n.d. n.d. 0.049 0.032 n.d. n.d.
HC single 0.006 0.159 n.d. n.d. 0.030 0.038 n.d. n.d. 0.008 0.175 n.d. n.d. 0.034 0.040 n.d. n.d.
HC average 0.004 0.315 n.d. n.d. 0.039 0.043 n.d. n.d. 0.016 0.113 n.d. n.d. 0.046 0.024 n.d. n.d.
HC ward 0.008 0.315 0.36 (0.00,
0.52)
0.060 0.020 0.58 (0.28,
0.72)
0.036 0.036 0.44 (0.00,
0.61)
0.063 0.023 0.62 (0.34,
0.73)
Mantel 0.014 0.712 0.00 (0.00,
0.80)
0.040 0.201 0.91 (0.00,
0.97)
0.005 0.516 0.00 (0.00,
0.76)
0.050 0.207 0.79 (0.00,
0.91)
Blomberg K 0.002 0.305 0.50 (0.00,
0.67)
0.025 0.366 0.44 (0.00,
0.72)
0.091 0.038 0.71 (0.00,
0.82)
0.593 0.080 0.42 (0.00,
0.54)
PICv 1594 0.307 n.d. n.d. 127 0.345 n.d. n.d. 40.2 0.052 n.d. n.d. 5.58 0.002 n.d. n.d.
Pagel  0.105 0.016 0.44 (0.16,
0.57)
0.216 0.030 0.44 (0.00,
0.57)
0.153 0.025 0.45 (0.00,
0.59)
0.646 0.016 0.54 (0.32,
0.63)
AM oriAbouheif 0.013 0.680 n.d. n.d. 0.016 0.361 n.d. n.d. 0.038 0.141 n.d. n.d. 0.127 0.023 n.d. n.d.
AM Abouheif 0.014 0.671 0.01 (0.00,
0.32)
0.015 0.338 0.24 (0.00,
0.49)
0.037 0.138 0.31 (0.00,
0.48)
0.126 0.019 0.49 (0.03,
0.61)
AM sumDD 0.000 0.166 n.d. n.d. 0.001 0.168 n.d. n.d. 0.001 0.136 n.d. n.d. 0.013 0.016 n.d. n.d.
AM nNodes 0.000 0.166 n.d. n.d. 0.001 0.168 n.d. n.d. 0.001 0.136 n.d. n.d. 0.013 0.016 n.d. n.d.
AM patristic 0.002 0.320 n.d. n.d. 0.002 0.155 n.d. n.d. 0.005 0.119 n.d. n.d. 0.000 0.054 n.d. n.d.
Individuals were subdivided according to variability of viral load (Strict), risk category (MSM) or both. P-values showing borderline significance (P< 0.1)
are in blue, and formal significance (P< 0.05) is in red, and confidence intervals in which the lower limit is above zero are also in red. n.d., not done.
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In spite of significant heritability being found
in previous work on the Rakai data [34], we did
not consistently find heritability in this cohort.
Although they are not strictly comparable, the
results from the previous studies of the Rakai
and Swiss data suggest that heritability is higher
in the latter cohort, and this may underlie the
differences in our results. However, the best esti-
mate for h2 from the Rakai data was high (0.51)
(Table 1).
Six different subdivisions of the Netherlands data
were analysed using PP and Pagel’s , and only a
single positive result was found with one statistic
() in one subdivision, suggesting that heritability
is close to the detection borderline. It was estimated
at h2 = 0.52 (Table 3), which falls high within the
range of previous estimates [30].
It is interesting that the Swiss cohort shows more
apparent heritability than the Netherlands in spite of
a similar transmission routes and genetic back-
grounds. One potential explanation would be differ-
ences in coverage. The prevalence in Switzerland is
higher (0.4% compared with 0.2%) [63], but so is the
sample size (661 compared with 416) which sug-
gests similar levels of coverage, which are reportedly
high in both cohorts [47, 64]. In the Swiss dataset,
the mean SPVL of the Strict group is significantly
higher than that of the rest (P = 0.0004), and the
same is true of the MSM over non-MSM
(P = 0.003) [36]. The same is not true of these two
categories in the Netherlands cohort (data not
shown), which suggests that viral virulence geno-
types are less structured in this cohort and may
explain lower heritability.
The exclusion of non-Strict individuals generally
increased the level of significance, but this was
dependent on the cohort and the method. In the
Swiss cohort, the exclusion increased significance
when using the PP and HC methods, but not other-
wise (Table 2). In the Netherlands cohort, the exclu-
sion increased significance markedly when using
Pagel’s , but not as much using PP (Table 3).
Understanding why the Strict population exhibits
higher heritability than whole sample may be an im-
portant step in both estimating and understanding
the mechanisms behind heritability. Simple models
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Figure 1. Heritability estimated by ABC in all subdivisions of the Swiss data. The subdivision is written above the plot. Results
from the PP method are in red, and from Pagel’s  in blue, with the overlap in purple
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fitted to longitudinal viral load data within patients
suggest that fluctuations do not just represent ran-
dom noise [65]. Fluctuating viral load has been
associated with untreated sexually transmitted co-
infections [66] and this or other host-mediated effect
may mask the effect of the viral genotype and justify
the exclusion of individuals with highly variable viral
loads.
The same gene pol was used to analyse the Swiss
and Netherlands datasets, whereas the available
genes from the Rakai cohort were env and gag. It
has been shown that env and pol produce similar
trees [67], but there are topological differences,
and our work also demonstrates different results be-
tween gag and env (Fig. 2). The ABC method of esti-
mation by simulation makes estimation of h2 robust
to differences in gene usage and we do not expect
systematic differences between the cohorts. There
are also differences in transmission routes between
the cohorts, and a higher diversity of HLA types in
African than European populations [68]. Although
these differences inhibit direct comparability be-
tween the European and Ugandan datasets, they
add to the general nature of this work.
Figure 2. Heritability estimated by ABC in all subdivisions of the Rakai data. The subdivision is written above the plot. Results
from the PP method are in red, and from Pagel’s  in blue, with the overlap in purple
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Which method is best for detecting heritability?
The principle test of these statistics is the detection
of an effect in real data. Pagel’s  detected heritabil-
ity in every subdivision of the Swiss data (Table 2),
and also produced the strongest result of any statis-
tic applied to the Rakai dataset (Table 1). The PP and
HC statistics performed well on the Swiss data, par-
ticularly on the Strict subdivisions. The AM statistics
were less successful at detecting an effect in the
Swiss data. In the Rakai data, the AM ‘patristic’ vari-
ant found a significant result in two subdivisions.
However, in simulation studies it performed very
poorly (Supplementary Fig. S6).
Testing the detection power by simulation relies
on a simple model of trait evolution, but has the
advantage that heritability is known. It revealed that
the PP, HC, Pagel’s  and AM statistics were com-
parably sensitive, detecting an effect at greater than
approximately 0.4 heritability in the Swiss data, with
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Figure 3. Comparison of the sensitivity of various statistics to
heritability on the entire Swiss phylogeny. (Left side) The rela-
tionship between heritability and six different statistics under
comparison. The circles and bars represent the mean and
standard deviation of the sample. (Right side) The power of
each statistic to detect heritability at 5% significance. The bars
represent the standard deviation of the proportion
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Figure 4. Comparison of the sensitivity of various statistics
on the Swiss MSM Strict phylogeny. Left and right side as in
Figure 3
218 | Shirreff et al. Evolution, Medicine, and Public Health
 at Zentralbibliothek on M
ay 2, 2014
http://em
ph.oxfordjournals.org/
D
ow
nloaded from
 
AM slightly more sensitive (Figs 3 and 4). The K
statistic was as sensitive as other statistics when
applied to the MSM Strict subdivision, but in the
entire Swiss dataset its sensitivity was low.
Simulations suggest that none of the methods
can detect heritability lower than approximately
h2 = 0.4, and this threshold is higher in some
phylogenies. This threshold is confirmed by the
finding that estimates of h2 are always above 0.4
when heritability was found to be significant. Most
studies have estimated lower heritability than this
[30], and previous modelling work has suggested
that such low heritability is enough to produce a
substantial rate of evolution [15]. This suggests that
phylogenetic methods are not adequate to exclude
the possibility of relevant heritability in HIV viru-
lence in these datasets.
Interestingly, another study which took an analyt-
ical and computational approach to comparing be-
tween Blomberg’s K, the AM and the Mantel test
found that K had a higher power to detect an effect
than the AM statistic [69]. They also argue that these
tests should all give the same significance as they are
based on the cross-product of a phylogenetic simi-
larity and trait similarity matrix. In contrast, we
found marked differences between their perform-
ances, with the AM, K and Mantel statistic having
decreasing power to detect an effect. They found that
the sensitivity of these methods was dependent on
the shape of the phylogeny, so differences in the
source of trees (simulated versus inferred) are a pos-
sible source of discrepancy in the respective studies.
This is beyond the scope of this study but deserves to
be the subject of future work.
The PP, along with the HC methods, is able to
account for cofactors of SPVL: ignoring these may
lead to overestimates or underestimates of heritabil-
ity if they associate or dissociate on the tree, respect-
ively. Indeed, an increase in signal when cofactors
were taken into account was seen in previous ana-
lysis of transmission pairs in the Rakai cohort [34].
However, in the absence of a method to include the
effect of cofactors in simulations, this aspect of the
PP or HC methods cannot be harnessed to measure
h2. One possible method would be to calculate the
fixed effects of the cofactors using a linear regres-
sion, simulate only the residuals, and subsequently
add the fixed effects, but this requires treating re-
siduals as data, which is inappropriate in the likely
event that there is correlation between the effects of
cofactors and the SPVL [70]. The PP method pro-
duces a dataset of couples, which is analogous to
other couples studies [31–34]. The lack of sensitivity
of the PP method and the other phylogenetic
methods suggests that the phylogeny cannot (yet)
tell us everything that the epidemiology does about
the transmission network.
The  statistic has the advantage that it incorpor-
ates both topology and branch lengths, and analyses
the entire sample. It is notable, therefore, that the PP
method is relatively successful in spite of its
analysing only a subset of individuals who form ap-
parent transmission pairs (60%), and in particular
ignores deep relationships within the phylogeny.
Table 3. The statistics (Z), P-values from a randomization test, medians and confidence intervals of h2
from MHT on the Netherlands data, when analyzed with PP and Pagel’s 
All Strict MSM MSM Strict MSM NL MSM NL Strict
n 416 246 348 211 286 174
PP
Z 0.0627 0.2193 0.0763 0.2047 0.0633 0.2277
P-value 0.703 0.111 0.272 0.128 0.327 0.130
h2 0.02 0.01 0.08 0.09 0.29 0.40
95% CI (0.00, 0.45) (0.00, 0.56) (0.00, 0.53) (0.00, 0.47) (0.00, 0.63) (0.00, 0.67)
Pagel’s 
Z 0.0001 0.0978 0.0001 0.0323 0.0001 0.2628
P-value 0.824 0.086 0.827 0.200 0.718 0.038
h2 0.19 0.44 0.01 0.38 0.10 0.52
95% CI (0.00, 0.50) (0.00, 0.60) (0.00, 0.51) (0.00, 0.60) (0.00, 0.55) (0.00, 0.63)
Individuals were subdivided according to variability of viral load (Strict), risk category (MSM) or whether they were from the Netherlands (NL). P-values
showing borderline significance (P< 0.1) are in blue, and formal significance (P< 0.05) is in red, and confidence intervals in which the lower limit is
above zero are also in red.
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This suggests that most signal lies in the recent
phylogenetic relationships. However, in unpub-
lished work, Hodcroft et al. found SPVL heritability
using pedigree analysis on UK data [71]. In contrast
to our work, they found that collapsing poorly sup-
ported nodes in the tree and thereby ignoring some
of the shallow relationships in the phylogeny had a
negligible effect on their results for some datasets.
The AM method is also successful, which (with the
exception of the ‘patristic’ variant) ignores branch
lengths, indicating that topology may be more im-
portant. Rigorously identifying which clades or levels
of the phylogeny are responsible for heritability
would be an interesting direction for future research.
This may differ for phylogenies which are less star-
like than HIV. The use of longer sequences and bet-
ter sampled datasets is likely to result in better
detection and estimation of heritability, as poorly
resolved trees scramble the heritability signal.
However, the detection threshold is unlikely to
change even with improved sampling, as it was
based on simulations which were blind to uncer-
tainty in the tree.
It is noteworthy that the PP and Pagel’s  each
have their strengths in estimating the distributions
of h2 in the different Rakai subdivisions. The PP
Figure 5. Heritability estimated by ABC in all subdivisions of the Netherlands data. The subdivision is written above the plot.
Results from the PP method are in red, and from Pagel’s  in blue, with the overlap in purple
220 | Shirreff et al. Evolution, Medicine, and Public Health
 at Zentralbibliothek on M
ay 2, 2014
http://em
ph.oxfordjournals.org/
D
ow
nloaded from
 
method identifies a more strongly positive distribu-
tion in subdivision gp41, which Pagel’s  does not,
but the latter detects a more positive distribution in
p24 and subtype A gp41. This suggests that an ap-
proach which combines these methods may be
appropriate.
CONCLUSIONS AND IMPLICATIONS
In this study, we compare several phylogenetic com-
parative methods to detect heritability, h2. Many
methods detect heritability successfully in real and
simulated data, but sensitivity drops off below
h2 = 0.4. We recommend the PP method and
Pagel’s  for use in detecting and estimating herit-
ability, the former for its consideration of co-factors,
and the latter for its marginally higher level of
sensitivity.
Estimates of heritability were consistent with pre-
vious studies on the Rakai and Swiss data, and con-
firm that heritability can be very high, which has
clinical and evolutionary implications. When applied
to the Netherlands data, heritability was found only
in the most homogeneous subdivision, MSM who
originate in the Netherlands with Strict viral
loads. Differences in heritability between cohorts,
subdivisions and methods for estimation carry
implications for the biology of heritability,
which offer interesting avenues for future modelling
work. Experimental and epidemiological research
are also required to directly identify viral factors
which contribute to variance in SPVL, as well as
exploring the impact of treatment on virulence
evolution.
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Supplementary data are available at EMPH online.
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